Literature DB >> 6877767

Posterior chamber intraocular lens implantation by ophthalmology residents. A prospective study of cataract surgery.

B R Straatsma, K T Meyer, J V Bastek, D O Lightfoot.   

Abstract

The UCLA Cataract Surgery Study Group evaluated extracapsular cataract extraction with posterior chamber intraocular lens implantation (ECCE-posterior chamber IOL) performed by eight senior ophthalmology residents with faculty supervision and five faculty ophthalmologists experienced in intraocular lens surgery. The first 18 consecutive ECCE-posterior chamber IOL operations performed by each resident and faculty surgeon after July 1, 1981, were analyzed. All 234 operations and follow-up conformed to a predetermined protocol. Resident surgery achieved 20/40 or better final visual acuity in 88% of eyes; faculty surgery achieved 20/40 or better in 89%. Excluding cases with macular degeneration or other pre-existing eye disease, resident surgery achieved 20/40 or better final visual acuity in 95% of eyes; faculty surgery achieved 20/40 or better in 96%. There was no statistically significant difference between the results of resident surgery and faculty surgery. With supervision, ophthalmology residents achieved results generally equivalent to results obtained by experienced ophthalmic surgeons.

Entities:  

Mesh:

Year:  1983        PMID: 6877767     DOI: 10.1016/s0161-6420(83)34551-6

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  3 in total

Review 1.  The incidence, pathogenesis and treatment of cystoid macular edema following cataract surgery.

Authors:  A J Flach
Journal:  Trans Am Ophthalmol Soc       Date:  1998

2.  Periodic health examination, 1995 update: 3. Screening for visual problems among elderly patients. Canadian Task Force on the Periodic Health Examination.

Authors: 
Journal:  CMAJ       Date:  1995-04-15       Impact factor: 8.262

3.  Simultaneous bilateral cataract extraction in the UK.

Authors:  S Beatty; R K Aggarwal; D B David; M Guarro; H Jones; J L Pearce
Journal:  Br J Ophthalmol       Date:  1995-12       Impact factor: 4.638

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.